Author:
Sepulveda Gian P.,Gushchanskaia Ekaterina S.,Mora-Martin Alexandra,Esse Ruben,Nikorich Iana,Ceballos Ainhoa,Kwan Julian,Blum Benjamin C.,Dholiya Prakruti,Emili Andrew,Perissi Valentina,Cardamone Maria D.,Grishok Alla
Abstract
SUMMARYThe proto-oncogene c-MYC is a key representative of the MYC transcription factor network regulating growth and metabolism. MML-1 (Myc- and Mondo-like) is its homolog inC. elegans. The functional and molecular cooperation between c-MYC and H3 lysine 79 methyltransferase DOT1L was demonstrated in several human cancer types, and we have earlier discovered the connection betweenC. elegansMML-1 and DOT-1.1. Here, we demonstrate the critical role of DOT1L/DOT-1.1 in regulating c-MYC/MML-1 target genes genome-wide by ensuring the removal of “spent” transcription factors from chromatin by the nuclear proteasome. Moreover, we uncover a previously unrecognized proteolytic activity of DOT1L, which may facilitate c-MYC turnover. This new mechanism of c-MYC regulation by DOT1L may lead to the development of new approaches for cancer treatment.
Publisher
Cold Spring Harbor Laboratory